The Lab Rats

The group is developing novel immunotherapies using the Adeno-associated virus (AAV) gene-therapy platform that are capable of not only preventing development of disease, but can also stop preexisting (reverse) disease in mouse models of Multiple Sclerosis.

PRINCIPAL INVESTIGATOR

Brad Hoffman

Dr. Hoffman is an Associate Professor and cellular immunologist with a major interest in immune modulation and tolerance induction using adeno-associated virus (AAV) gene therapy. Dr. Hoffman earned his Ph.D. in Immunology from Temple University School of Medicine in 2006. He subsequently performed postdoctoral research in gene therapy at University of Florida.

Brad Hoffman

UF Pediatric News

When Can Kids Get The COVID-19 Vaccine — And What Should Parents Know Now?

Pfizer said on Monday that its two-dose COVID vaccine works for children ages 5 to 11 and that it plans to seek authorization from regulatory agencies as soon as possible.

College Diabetes Network Bowling Social

Join our first meeting of the year and meet others with diabetes! Friends are welcome and refreshments will be provided. Sunday, September 26, 20215:00 P.M. – 6:30 P.M.Reitz Union Game…

7th Annual Pediatric Medical Student Research Forum

Despite the challenges of this past year, the Department of Pediatrics and the University of Florida College of Medicine sponsored the 7th Annual Pediatric Medical Student Research Forum this past…

Breast milk of mothers who received COVID-19 vaccine contains antibodies that fight illness

During this vulnerable period, breast milk allows nursing mothers to provide infants with “passive immunity,” Neu explained.